KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash & Current Investments (2016 - 2026)

Bristol Myers Squibb has reported Cash & Current Investments over the past 18 years, most recently at $10.5 billion for Q1 2026.

  • Quarterly Cash & Current Investments fell 11.0% to $10.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $10.5 billion through Mar 2026, down 11.0% year-over-year, with the annual reading at $10.7 billion for FY2025, 1.71% down from the prior year.
  • Cash & Current Investments was $10.5 billion for Q1 2026 at Bristol Myers Squibb, down from $10.7 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $16.5 billion in Q3 2025 and troughed at $6.7 billion in Q2 2024.
  • The 5-year median for Cash & Current Investments is $10.5 billion (2026), against an average of $10.8 billion.
  • Year-over-year, Cash & Current Investments crashed 45.46% in 2022 and then surged 104.46% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $9.3 billion in 2022, then surged by 32.71% to $12.3 billion in 2023, then fell by 11.57% to $10.9 billion in 2024, then decreased by 1.71% to $10.7 billion in 2025, then decreased by 1.75% to $10.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Cash & Current Investments are $10.5 billion (Q1 2026), $10.7 billion (Q4 2025), and $16.5 billion (Q3 2025).